Page last updated: 2024-11-08

pentylenetetrazole and Liver Diseases

pentylenetetrazole has been researched along with Liver Diseases in 2 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Liver Diseases: Pathological processes of the LIVER.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SCHIFFMAN, DO1
SWINYARD, EA1
GOODMAN, LS1
Weinhold, D1
Reske, W1

Other Studies

2 other studies available for pentylenetetrazole and Liver Diseases

ArticleYear
Effect of liver damage and nephrectomy on convulsant potency of pentylenetetrazol (metrazol).
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1955, Volume: 90, Issue:1

    Topics: Abdominal Injuries; Convulsants; Humans; Kidney; Liver; Liver Diseases; Nephrectomy; Pentylenetetraz

1955
[Incidents with mild shock symptoms in Wofaverdin tests].
    Zeitschrift fur arztliche Fortbildung, 1971, Nov-01, Volume: 65, Issue:21

    Topics: Adult; Anaphylaxis; Coloring Agents; Cyanides; Drug Hypersensitivity; Dyspnea; Female; Glucose; Huma

1971